Alberto Martini

Ben-David R.; Pellegrino F.; Alerasool P.; Tillu N.; Lavallee E.; Attalla K.; Waingankar N.; John S.P.; Mehrazin R.; Moschini M.; Martini A.; Edeling S.; Briganti A.; Montorsi F.; Wiklund P. 12-01-2024. Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analys World Journal of Urology, 42 1,

d’Agate D.; Martini A.; Lesourd M.; Tollon C.; Loison G.; Almeras C.; Pradère B.; Salin A.; Beauval J.B.; Ploussard G. 12-01-2024. Patient experience and satisfaction after same-day discharge radical prostatectomy using a personali World Journal of Urology, 42 1,

Martini A.; Ploussard G. 12-01-2023. Reply to: Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biop Prostate Cancer and Prostatic Diseases, 26 4, 802-803

Martini A.; Touzani A.; Mazzone E.; Roumiguié M.; Marra G.; Valerio M.; Beauval J.B.; Campi R.; Minervini A.; van den Berg R.C.N.; van den Berg R.C.N.; Soeterik T.F.W.; Zhuang J.; Guo H.; Gontero P.; Montorsi F.; Briganti A.; Gandaglia G.; Ploussard G. 12-01-2023. Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: fac Prostate Cancer and Prostatic Diseases, 26 4, 806

Fallara G.; Fankhauser C.D.; Martini A. 12-01-2022. Comment on: “Improving the stratification of intermediate risk prostate cancer” Minerva Urology and Nephrology, 74 6, 819-821

Maggi M.; Gandaglia G.; Rajwa P.; Martini A.; Marra G. 12-01-2022. The current evidence on prognostic factors in metastatic castration-resistant prostate cancer patien Minerva Urology and Nephrology, 74 6, 791-793

Martini A.; Touzani A.; Beauval J.B.; Ruffion A.; Olivier J.; Gasmi A.; Dariane C.; Thoulouzan M.; Barret E.; Brureau L.; Créhange G.; Fiard G.; Gauthé M.; Renard-Penna R.; Roubaud G.; Sargos P.; Roumiguié M.; Timsit M.O.; Mathieu R.; Villers A.; Rouprêt M.; Fromont G.; Ploussard G. 12-01-2022. Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens World Journal of Urology, 40 12, 2931-2937

Falagario U.G.; Jambor I.; Lantz A.; Ettala O.; Stabile A.; Taimen P.; Aronen H.J.; Knaapila J.; Perez I.M.; Gandaglia G.; Fossati N.; Martini A.; Cucchiara V.; Picker W.; Haug E.; Ratnani P.; Haines K.; Lewis S.; Sujit N.; Selvaggio O.; Sanguedolce F.; Macarini L.; Cormio L.; Nordström T.; Tewari A.; Briganti A.; Boström P.J.; Carrieri G. 12-01-2021. Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy European urology oncology, 4 6, 971-979

Martini A.; Turri F.; Barod R.; Rocco B.; Capitanio U.; Briganti A.; Montorsi F.; Mottrie A.; Challacombe B.; Lagerveld B.W.; Bensalah K.; Abaza R.; Badani K.K.; Mehrazin R.; Buscarini M.; Larcher A.; Okhawere K.; Martinez O.E.; Khene Z.E.; Sonpreet R.; Campain N.; De Groote R.; Dell'Oglio P.; Grivas N.; Goonewardene S.; Hemal A.; Rivas J.G. 12-01-2021. Salvage Robot-assisted Renal Surgery for Local Recurrence After Surgical Resection or Renal Mass Abl European Urology, 80 6, 730-737

Anastos H.; Martini A.; Waingankar N.; Paulucci D.J.; Beksac A.T.; Daza J.; Patel H.V.; Gin G.E.; Sfakianos J.P.; Badani K.K. 12-01-2020. Black race may be associated with worse overall survival in renal cell carcinoma patients Urologic Oncology: Seminars and Original Investigations, 38 12, 938.e9-938.e17

Falagario U.G.; Jambor I.; Ratnani P.; Martini A.; Treacy P.J.; Wajswol E.; Lantz A.; Papastefanou G.; Weil R.; Phillip D.; Lewis S.; Haines K.; Cormio L.; Carrieri G.; Kyprianou N.; Wiklund P.; Tewari A.K. 12-01-2020. Performance of prostate multiparametric Mri for prediction of prostate cancer extra-prostatic extens Minerva Urologica e Nefrologica, 72 6, 746-754

Gandaglia G.; Ploussard G.; Valerio M.; Marra G.; Moschini M.; Martini A.; Roumiguié M.; Fossati N.; Stabile A.; Beauval J.B.; Malavaud B.; Scuderi S.; Barletta F.; Afferi L.; Rakauskas A.; Gontero P.; Mattei A.; Montorsi F.; Briganti A. 12-01-2020. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Bio European urology oncology, 3 6, 739-747

Martini A.; Pfail J.; Montorsi F.; Galsky M.D.; Oh W.K. 12-01-2020. Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate can Prostate Cancer and Prostatic Diseases, 23 4, 638-645

Moschini M.; Martini A.; Zamboni S.; Mattei A.; Baumeister P.; Di Bona C.; Dell'Oglio P.; Zaffuto E.; Burgio G.; Shariat S.F.; Sanchez-Salas R.; Cathelineau X.; Salonia A.; Montorsi F.; Briganti A.; Gallina A.; Colombo R. 12-01-2019. Re: Evaluation of Cause of Death after Radical Cystectomy for Patients with Bladder Cancer: The Impa Journal of Urology, 202 6, 1076-1077

Niglio S.A.; Jia R.; Ji J.; Ruder S.; Patel V.G.; Martini A.; Sfakianos J.P.; Marqueen K.E.; Waingankar N.; Mehrazin R.; Wiklund P.; Oh W.K.; Mazumdar M.; Ferket B.S.; Galsky M.D. 12-01-2019. Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metasta European Urology, 76 6, 782-789

Beksac A.T.; Cumarasamy S.; Falagario U.; Xu P.; Takhar M.; Alshalalfa M.; Gupta A.; Prasad S.; Martini A.; Thulasidass H.; Rai R.; Berger M.; Hectors S.; Jordan J.; Davicioni E.; Nair S.; Haines K.; Lewis S.; Rastinehad A.; Yadav K.; Jayaratna I.; Taouli B.; Tewari A. 12-01-2018. Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Pheno Journal of Urology, 200 6, 1241-1249

Martini A.; Cumarasamy S.; Beksac A.T.; Abaza R.; Eun D.D.; Bhandari A.; Hemal A.K.; Porter J.R.; Badani K.K. 12-01-2018. A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Parti European Urology, 74 6, 833-839

Martini A.; Gandaglia G.; Nicita G.; Montorsi F. 12-01-2018. A Novel Classification Proposal for Rectourethral Fistulas After Primary Treatment of Prostate Cance European Urology Oncology, 1 6, 510-511

Martini A.; Gupta A.; Lewis S.; Cumarasamy S.; Haines K.; Briganti A.; Montorsi F.; Tewari A. 12-01-2018. Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-b BJU International, 122 6, 1025-1033

Nicita G.; Martini A.; Filocamo M.; Saieva C.; Tosto A.; Stomaci N.; Bigazzi B.; Villari D. 12-01-2016. Use of sigmoid colon in orthotopic neobladder reconstruction: Long-term results International Journal of Urology, 23 12, 984-990

Nicita G.; Martini A.; Filocamo M.; Saieva C.; Tosto A.; Stomaci N.; Bigazzi B.; Villari D. 12-01-2016. Response to Editorial Comment to Use of sigmoid colon in orthotopic neobladder reconstruction: Long- International Journal of Urology, 23 12, 991

Martini A.; Dattolo E.; Raspollini M.; Villari D.; Nicita G.; Paoletti M. 11-18-2016. Conservative approach for a solitary fibrous tumor of the kidney Urologia, 83 4, 221-223

Martini A.; Falagario U.G.; Russo A.; Mertens L.S.; Di Gianfrancesco L.; Bravi C.A.; Vollemaere J.; Abdeen M.; Mendrek M.; Kjøbli E.; Buse S.; Wijburg C.; Touzani A.; Ploussard G.; Antonelli A.; Schwenk L.; Ebbing J.; Vasdev N.; Froelicher G.; John H.; Canda A.E.; Balbay M.D.; Stoll M.; Edeling S.; Witt J.H.; Leyh-Bannurah S.R.; Siemer S.; Stoeckle M.; Mottrie A.; D'Hondt F.; Crestani A.; Porreca A.; van der Poel H.; Decaestecker K.; Gaston R.; Peter Wiklund N.; Hosseini A. 11-01-2023. Robot-assisted Radical Cystectomy with Orthotopic Neobladder Reconstruction: Techniques and Function European Urology, 84 5, 484-490

Belladelli F.; Montorsi F.; Martini A. 11-01-2022. Metabolic syndrome, obesity and cancer risk Current Opinion in Urology, 32 6, 594-597

Fallara G.; Belladelli F.; Robesti D.; Raggi D.; Nocera L.; Marandino L.; Galsky M.D.; Montorsi F.; Malavaud B.; Ploussard G.; Necchi A.; Martini A. 11-01-2022. Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castr Critical Reviews in Oncology/Hematology, 179 ,

Fallara G.; Larcher A.; Rosiello G.; Raggi D.; Marandino L.; Martini A.; Basile G.; Colandrea G.; Cignoli D.; Belladelli F.; Re C.; Musso G.; Cei F.; Bertini R.; Briganti A.; Salonia A.; Montorsi F.; Necchi A.; Capitanio U. 11-01-2022. How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit th World Journal of Urology, 40 11, 2667-2673

Fallara G.; Robesti D.; Nocera L.; Raggi D.; Marandino L.; Belladelli F.; Montorsi F.; Malavaud B.; Ploussard G.; Necchi A.; Martini A. 11-01-2022. Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive pro Cancer Treatment Reviews, 110 ,

Martini A.; Mottet N.; Montorsi F.; Necchi A.; Ribal M.J.; Malavaud B. 11-01-2022. A Plea for Economically Sustainable Evidence-based Guidelines European Urology, 82 5, 449-451

Peters M.; Eldred-Evans D.; Kurver P.; Falagario U.G.; Connor M.J.; Shah T.T.; Verhoeff J.J.C.; Taimen P.; Aronen H.J.; Knaapila J.; Montoya Perez I.; Ettala O.; Stabile A.; Gandaglia G.; Fossati N.; Martini A.; Cucchiara V.; Briganti A.; Lantz A.; Picker W.; Haug E.S.; Nordström T.; Tanaka M.B.; Reddy D.; Bass E.; van Rossum P.S.N.; Wong K.; Tam H.; Winkler M.; Gordon S.; Qazi H.; Boström P.J.; Jambor I.; Ahmed H.U. 11-01-2022. Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a M European Urology, 82 5, 559-568

Martini A.; Gandaglia G.; Briganti A. 11-01-2021. Evidence-based Urology: Surrogate Endpoints – For European Urology Focus, 7 6, 1217-1218

Veccia A.; Antonelli A.; Martini A.; Falagario U.; Carrieri G.; Grob M.B.; Guruli G.; Simeone C.; Wiklund P.; Porpiglia F.; Autorino R. 11-01-2020. Ureteral location is associated with survival outcomes in upper tract urothelial carcinoma: A popula International Journal of Urology, 27 11, 966-972

Villari D.; Salvianti F.; Zanazzi M.; Martini A.; Spatafora P.; Caroassai Grisanti S.; Sebastianelli A.; Nicita G.; Serni S.; Pinzani P. 11-01-2020. Quantitative Polymerase Chain Reaction Detection of Microchimerism in Female Transplant Renal Recipi Urologia Internationalis, 104 11-12, 865-870

Wang L.; Gong Y.; Saci A.; Szabo P.M.; Martini A.; Necchi A.; Siefker-Radtke A.; Pal S.; Plimack E.R.; Sfakianos J.P.; Bhardwaj N.; Horowitz A.; Farkas A.M.; Mulholland D.; Fischer B.S.; Oh W.K.; Sharma P.; Zhu J.; Galsky M.D. 11-01-2019. Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with European Urology, 76 5, 599-603

Katafigiotis I.; Sfoungaristos S.; Martini A.; Stravodimos K.; Anastasiou I.; Mykoniatis I.; Duvdevani M.; Constantinides C. 10-25-2017. Bladder cancer to patients younger than 30 years: a retrospective study and review of the literature Urologia, 84 4, 231-235

Martini A.; Fallara G.; Ploussard G.; Malavaud B. 10-01-2023. Combination therapy with olaparib and abiraterone acetate for metastatic castration-resistant prosta The Lancet Oncology, 24 10, 1056-1057

Treacy P.J.; Falagario U.G.; Magniez F.; Ratnani P.; Wajswol E.; Martini A.; Jambor I.; Wiklund P.; Bentellis I.; Barthe F.; Kyprianou N.; Durand M.; Steffens D.; Karunaratne S.; Leslie S.; Thanigasalam R.; Tewari A. 10-01-2023. Decipher Score predicts prostate specific antigen persistence after prostatectomy Minerva Urology and Nephrology, 75 5, 583-590

Cignoli D.; Fallara G.; Aleotti F.; Larcher A.; Rosiello G.; Rowe I.; Basile G.; Colandrea G.; Martini A.; De Cobelli F.; Brembilla G.; Lucianò R.; Colecchia M.; Lena M.S.; Partelli S.; Tamburrino D.; Zamboni G.; Rubini C.; Falconi M.; Montorsi F.; Salonia A.; Capitanio U. 10-01-2022. Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression World Journal of Urology, 40 10, 2481-2488

Martini A.; Bravi C.A. 10-01-2022. Acute kidney injury and functional outcomes after partial nephrectomy International Journal of Urology, 29 10, 1243-1244

Padua T.C.d.; Moschini M.; Martini A.; Pederzoli F.; Nocera L.; Marandino L.; Raggi D.; Briganti A.; Montorsi F.; Necchi A. 10-01-2022. Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: Urologic Oncology: Seminars and Original Investigations, 40 10, 413-423

Marandino L.; Raggi D.; Calareso G.; Alessi A.; Colecchia M.; Martini A.; Briganti A.; Montorsi F.; Madison R.; Ross J.S.; Necchi A. 10-01-2021. Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemother Clinical Genitourinary Cancer, 19 5, 457-465

Martini A.; Afferi L.; Zamboni S.; Schultz J.G.; Lonati C.; Mattei A.; Karnes R.J.; Soligo M.; Stabile A.; Di Trapani E.; De Cobelli O.; Simone G.; Simeone C.; Alvarez-Maestro M.; Gandaglia G.; Gallina A.; Colombo R.; Briganti A.; Montorsi F.; Xylinas E.; Shariat S.F.; Moschini M. 10-01-2021. Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy Journal of Urology, 206 4, 885-893

Falagario U.G.; Martini A.; Wajswol E.; Treacy P.J.; Ratnani P.; Jambor I.; Anastos H.; Lewis S.; Haines K.; Cormio L.; Carrieri G.; Rastinehad A.R.; Wiklund P.; Tewari A. 10-01-2020. Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive European urology oncology, 3 5, 700-704

Jambor I.; Falagario U.G.; Martini A.; Eldred-Evans D.; Ahmed H.U.; Boström P.J. 10-01-2020. Re: Antonio C. Westphalen, Charles E. McCulloch, Jordan M. Anaokar, et al. Variability of the Positi European urology oncology, 3 5, 714-715

Martini A.; Falagario U.G.; Villers A.; Dell'Oglio P.; Mazzone E.; Autorino R.; Moschovas M.C.; Buscarini M.; Bravi C.A.; Briganti A.; Sawczyn G.; Kaouk J.; Menon M.; Secco S.; Bocciardi A.M.; Wang G.; Zhou X.; Porpiglia F.; Mottrie A.; Patel V.; Tewari A.K.; Montorsi F.; Gaston R.; Wiklund N.P.; Hemal A.K. 10-01-2020. Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy European Urology, 78 4, 583-591

Gul Z.G.; Martini A.; Olsson C.A. 10-01-2019. Re: Jacob A. Burns, Adam B. Weiner, William J. Catalone, et al. Inflammatory Bowel Disease and the R European Urology, 76 4, e98

Martini A.; Cumarasamy S.; Gupta A.; Falagario U.G.; Shah Q.N.; Beksac A.T.; Haines K.G.; Tewari A.K. 10-01-2019. Clinical implications of prostatic capsular abutment or bulging on multiparametric magnetic resonanc Minerva Urologica e Nefrologica, 71 5, 502-507

Martini A.; Daza J.; Poltiyelova E.; Gul Z.; Heard J.R.; Ferket B.S.; Waingankar N.; Galsky M.D.; Sfakianos J.P. 10-01-2019. Pathological downstaging as a novel endpoint for the development of neoadjuvant chemotherapy for upp BJU International, 124 4, 665-671

Martini A.; Sfakianos J.P.; Galsky M.D. 10-01-2019. Conditionally Reprogrammed Patient-derived Cells: A Step Forward Towards Personalized Medicine? European Urology, 76 4, 435-436

Martini A.; Jia R.; Ferket B.S.; Waingankar N.; Plimack E.R.; Crabb S.J.; Harshman L.C.; Yu E.Y.; Powles T.; Rosenberg J.E.; Pal S.K.; Vaishampayan U.N.; Necchi A.; Wiklund N.P.; Mehrazin R.; Mazumdar M.; Sfakianos J.P.; Galsky M.D. 09-15-2019. Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy Cancer, 125 18, 3155-3163

Falagario U.G.; Abbadi A.; Remmers S.; Björnebo L.; Bogdanovic D.; Martini A.; Valdman A.; Carrieri G.; Menon M.; Akre O.; Eklund M.; Nordström T.; Grönberg H.; Lantz A.; Wiklund P. 09-05-2023. Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy JAMA network open, 6 9, e2332900

Nocera L.; Fallara G.; Raggi D.; Belladelli F.; Robesti D.; Montorsi F.; Karakiewicz P.I.; Malavaud B.; Ploussard G.; Necchi A.; Martini A. 09-05-2022. Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed sur Frontiers in Oncology, 12 ,

Halme A.L.E.; McAlpine K.; Martini A. 09-01-2023. Fixed-effect Versus Random-effects Models for Meta-analyses: Random-effects Models European Urology Focus, 9 5, 693-694

Martini A.; Touzani A.; Ploussard G. 09-01-2023. Lower Detrusor Apron–sparing Robot-assisted Radical Cystectomy and Intracorporeal Neobladder Reconst European Urology Focus, 9 5, 760-764

Venkatesh N.; Martini A.; McQuade J.L.; Msaouel P.; Hahn A.W. 09-01-2023. Obesity and renal cell carcinoma: Biological mechanisms and perspectives Seminars in Cancer Biology, 94 , 21-33

Lonati C.; Baumeister P.; Afferi L.; Mari A.; Minervini A.; Krajewski W.; Azizi S.; Hendricksen K.; Martini A.; Necchi A.; Montorsi F.; Briganti A.; Colombo R.; Tafuri A.; Antonelli A.; Cerruto M.A.; Rouprêt M.; Masson-Lecomte A.; Laukhtina E.; D'Andrea D.; Shariat S.F.; Soria F.; Marra G.; Gontero P.; Contieri R.; Hurle R.; Valiquette A.S.; Mir M.C.; Zamboni S.; Simeone C.; Klatte T.; Teoh J.Y.C.; Yoshida S.; Fujii Y.; Carando R.; Schulz G.B.; Mordasini L.; Mattei A.; Moschini M. 09-01-2022. Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Ca European Urology Focus, 8 5, 1270-1277

Martini A.; Fallara G.; Ploussard G.; Pradere B. 09-01-2022. Progression-free survival is an adequate endpoint for clinical trials of locally advanced and metast Current Opinion in Urology, 32 5, 500-503

Martini A.; Shah Q.N.; Waingankar N.; Sfakianos J.P.; Tsao C.K.; Necchi A.; Montorsi F.; Gallagher E.J.; Galsky M.D. 09-01-2022. The obesity paradox in metastatic castration-resistant prostate cancer Prostate Cancer and Prostatic Diseases, 25 3, 472-478

Martini A.; Parikh A.B.; Sfakianos J.P.; Montorsi F.; Galsky M.D.; Oh W.K.; Tsao C.K. 09-01-2021. Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration- Prostate Cancer and Prostatic Diseases, 24 3, 743-749

Moschini M.; Afferi L.; Gandaglia G.; D'Andrea D.; Zamboni S.; Di Bona C.; Mordasini L.; Mattei A.; Baumeister P.; Martini A.; Burgio G.; Shariat S.F.; Sanchez-Salas R.; Cathelineau X.; Stabile A.; Zaffuto E.; Salonia A.; Colombo R.; Necchi A.; Montorsi F.; Briganti A.; Gallina A. 09-01-2021. Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients European Urology Focus, 7 5, 1067-1074

Gupta S.S.; Martini A.; Wagaskar V.G.; Tewari A.K. 09-01-2019. Prostate Cancer in a Patient with Giant Prostatic Hyperplasia: The Robotic Approach to a Difficult P Journal of Endourology Case Reports, 5 3, 99-101

Martini A.; Cumarasamy S.; Tewari A.K. 08-09-2018. MRI-targeted biopsy for prostate-cancer diagnosis New England Journal of Medicine, 379 6, 589

Mercuri S.R.; Paolino G.; Brianti P.; Di Nicola M.R.; Martini A.; Necchi A.; Montorsi F. 08-05-2022. UltraPulse Carbon Dioxide Laser Plus Methyl Aminolevulinate-Photodynamic Therapy for the Treatment o Case Reports in Dermatology, 14 2, 210-213

Falagario U.G.; Knipper S.; Pellegrino F.; Martini A.; Akre O.; Egevad L.; Grönberg H.; Moschovas M.C.; Bravi C.A.; Tran J.; Heiniger Y.; von Kempis A.; Schaffar R.; Carrieri G.; Rochat C.H.; Mottrie A.; Ahlering T.E.; John H.; Patel V.; Graefen M.; Wiklund P. 08-01-2024. Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Year European urology oncology, 7 4, 705-712

Pellegrino F.; Falagario U.G.; Knipper S.; Martini A.; Akre O.; Egevad L.; Aly M.; Moschovas M.C.; Bravi C.A.; Tran J.; Heiniger Y.; von Kempis A.; Schaffar R.; Carrieri G.; Briganti A.; Montorsi F.; Rochat C.H.; Mottrie A.; Ahlering T.E.; John H.; Patel V.; Graefen M.; Wiklund P. 08-01-2024. Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Rad European urology oncology, 7 4, 888-896

Zattoni F.; Fasulo V.; Kasivisvanathan V.; Kesch C.; Marra G.; Martini A.; Falagario U.; Soeterik T.; van den Bergh R.; Rajwa P.; Gandaglia G. 08-01-2024. Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging–targeted Prostate Biopsy: European Urology Open Science, 66 , 16-25

Baboudjian M.; Gondran-Tellier B.; Touzani A.; Martini A.; Diamand R.; Roche J.B.; Lacetera V.; Beauval J.B.; Roumeguère T.; Simone G.; Benamran D.; Fourcade A.; Fiard G.; van den Bergh R.C.N.; Peltier A.; Ploussard G. 08-01-2023. Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatec European urology oncology, 6 4, 406-413

Musso G.; Fallara G.; Rosiello G.; Martini A.; Re C.; Cei F.; Basile G.; Cignoli D.; Colandrea G.; Rowe I.; Larcher A.; Salonia A.; Montorsi F.; Capitanio U. 08-01-2023. Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell C Clinical Genitourinary Cancer, 21 4, e279-e285.e1

Basile G.; Rosiello G.; Larcher A.; Fallara G.; Martini A.; Re C.; Cignoli D.; Tian Z.; Karakiewicz P.I.; Mottrie A.; Bertini R.; Necchi A.; Raggi D.; Salonia A.; Briganti A.; Montorsi F.; Capitanio U. 08-01-2022. Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell c Urologic Oncology: Seminars and Original Investigations, 40 8, 384.e15-384.e21

Capitanio U.; Fallara G.; Raggi D.; Nocera L.; Larcher A.; Belladelli F.; Rowe I.; Briganti A.; Salonia A.; Karakiewicz P.; Montorsi F.; Martini A.; Necchi A. 08-01-2022. Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence Current Problems in Cancer, 46 4,

Martini A.; Fallara G.; Pellegrino A.A.; Nocera L.; Larcher A.; Raggi D.; Campi R.; Ploussard G.; Malavaud B.; Montorsi F.; Pal S.K.; Spiess P.E.; Choueiri T.K.; Necchi A.; Capitanio U. 08-01-2022. Multidisciplinary team referral at diagnosis for patients with non-metastatic renal cell carcinoma Urologic Oncology: Seminars and Original Investigations, 40 8, 384.e9-384.e14

Martini A.; Lonati C.; Necchi A.; Galsky M.D.; Ploussard G.; Fallara G.; Pellegrino A.; Simeone C.; Suardi N.; Zamboni S.; Krajewski W.; Simone G.; Briganti A.; Montorsi F.; Mattei A.; Shariat S.F.; Moschini M. 08-01-2022. Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall S Clinical Genitourinary Cancer, 20 4, 389.e1-389.e7

Martini A.; Lonati C.; Nocera L.; Fallara G.; Raggi D.; Herout R.; Zamboni S.; Ploussard G.; Predere B.; Mattei A.; Simeone C.; Krajewski W.; Simone G.; Soria F.; Gontero P.; Roupret M.; Montorsi F.; Briganti A.; Shariat S.F.; Necchi A.; Moschini M. 08-01-2022. Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcino European urology oncology, 5 4, 451-459

Martini A.; Ploussard G. 08-01-2022. Re: Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 European Urology, 82 2, 241

Martini A.; Yu M.; Raggi D.; Joshi H.; Fallara G.; Montorsi F.; Necchi A.; Galsky M.D. 08-01-2022. Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potentia Cancer, 128 15, 2892-2897

Rosiello G.; Re C.; Larcher A.; Fallara G.; Sorce G.; Baiamonte G.; Mazzone E.; Bravi C.A.; Martini A.; Tian Z.; Mottrie A.; Bertini R.; Salonia A.; Briganti A.; Montorsi F.; Capitanio U.; Karakiewicz P.I. 08-01-2022. The effect of frailty on post-operative outcomes and health care expenditures in patients treated wi European Journal of Surgical Oncology, 48 8, 1840-1847

BRAVI C.A.; ROSIELLO G.; FALLARA G.; VERTOSICK E.; TIN A.; SJOBERG D.; BIANCHI M.; MAZZONE E.; MARTINI A.; DELL'OGLIO P.; STABILE A.; GANDAGLIA G.; FOSSATI N.; BRIGANTI A.; MONTORSI F.; VICKERS A. 08-01-2021. Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: Result Minerva Urology and Nephrology, 73 4, 481-488

Di Marco F.; Pani A.; Floris M.; Martini A.; Dell’antonio G.; Capitanio U.; Bettiga A.; Larcher A.; Cinque A.; Bertini R.; Briganti A.; Salonia A.; Montorsi F.; Trevisani F. 08-01-2021. Unexpected outcomes of renal function after radical nephrectomy: Histology relevance along with clin Journal of Clinical Medicine, 10 15,

Wagaskar V.G.; Mittal A.; Sobotka S.; Ratnani P.; Lantz A.; Falagario U.G.; Martini A.; Dovey Z.; Treacy P.J.; Pathak P.; Nair S.; Roy B.; Chakravarty D.; Lewis S.; Haines K.; Wiklund P.; Tewari A. 08-01-2021. Hood Technique for Robotic Radical Prostatectomy—Preserving Periurethral Anatomical Structures in th European Urology, 80 2, 213-221

Gandaglia G.; Martini A.; Ploussard G.; Fossati N.; Stabile A.; De Visschere P.; Borgmann H.; Heidegger I.; Steinkohl F.; Kretschmer A.; Marra G.; Mathieu R.; Surcel C.; Tilki D.; Tsaur I.; Valerio M.; Van den Bergh R.; Ost P.; Gontero P.; Montorsi F.; Briganti A. 08-01-2020. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients European Urology, 78 2, 138-142

Martini A.; Falagario U.G.; Waingankar N.; Daza J.; Treacy P.J.; Necchi A.; Galsky M.D.; Sfakianos J.P. 08-01-2020. Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma Urologic Oncology: Seminars and Original Investigations, 38 8, 684.e9-684.e15

Santi R.; Martini A.; Villari D.; Nesi G. 08-01-2018. Ureteritis Cystica Presenting as a Single Polypoid Mass International Journal of Surgical Pathology, 26 5, 437-438

Martini A.; Villari D.; Nicita G. 08-01-2017. Long-term complications arising from bowel interposition in the urinary tract International Journal of Surgery, 44 , 278-280

Martini A.; Dattolo E.; Frizzi J.; Villari D.; Paoletti M. 08-01-2016. Robotic vesico-vaginal fistula repair with no omental flap interposition International Urogynecology Journal, 27 8, 1277-1278

Martini A.; Wever L.; Soeterik T.F.W.; Rakauskas A.; Fankhauser C.D.; Grogg J.B.; Checcucci E.; Amparore D.; Haiquel L.; Rodriguez-Sanchez L.; Ploussard G.; Qiang P.; Affentranger A.; Marquis A.; Marra G.; Ettala O.; Zattoni F.; Falagario U.G.; De Angelis M.; Kesch C.; Apfelbeck M.; Al-Hammouri T.; Kretschmer A.; Kasivisvanathan V.; Preisser F.; Lefebvre E.; Olivier J.; Radtke J.P.; Briganti A.; Montorsi F.; Carrieri G.; Moro F.D.; Boström P.; Jambor I.; Gontero P.; Chiu P.K.; John H.; MacEk P.; Porpiglia F.; Hermanns T.; Van Den Bergh R.C.N.; Van Basten J.P.A.; Gandaglia G.; Valerio M. 07-01-2023. Reply by Authors Journal of Urology, 210 1, 127

Martini A.; Wever L.; Soeterik T.F.W.; Rakauskas A.; Fankhauser C.D.; Grogg J.B.; Checcucci E.; Amparore D.; Haiquel L.; Rodriguez-Sanchez L.; Ploussard G.; Qiang P.; Affentranger A.; Marquis A.; Marra G.; Ettala O.; Zattoni F.; Falagario U.G.; De Angelis M.; Kesch C.; Apfelbeck M.; Al-Hammouri T.; Kretschmer A.; Kasivisvanathan V.; Preisser F.; Lefebvre E.; Olivier J.; Radtke J.P.; Briganti A.; Montorsi F.; Carrieri G.; Moro F.D.; Boström P.; Jambor I.; Gontero P.; Chiu P.K.; John H.; MacEk P.; Porpiglia F.; Hermanns T.; Van Den Bergh R.C.N.; Van Basten J.P.A.; Gandaglia G.; Valerio M. 07-01-2023. Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Journal of Urology, 210 1, 117-126

Zattoni F.; Marra G.; Martini A.; Kasivisvanathan V.; Grummet J.; Harkin T.; Ploussard G.; Olivier J.; Chiu P.K.; Valerio M.; Marquis A.; Gontero P.; Guo H.; Zhuang J.; Frydenberg M.; Moon D.; Morlacco A.; Kretschmer A.; Barletta F.; Heidegger I.; Tilki D.; van den Bergh R.; Dal Moro F.; Briganti A.; Montorsi F.; Novara G.; Gandaglia G. 07-01-2023. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy on European Urology Focus, 9 4, 621-628

Parekh S.; Ratnani P.; Falagario U.; Lundon D.; Kewlani D.; Nasri J.; Dovey Z.; Stroumbakis D.; Ranti D.; Grauer R.; Sobotka S.; Pedraza A.; Wagaskar V.; Mistry L.; Jambor I.; Lantz A.; Ettala O.; Stabile A.; Taimen P.; Aronen H.J.; Knaapila J.; Perez I.M.; Gandaglia G.; Martini A.; Picker W.; Haug E.; Cormio L.; Nordström T.; Briganti A.; Boström P.J.; Carrieri G.; Haines K.; Gorin M.A.; Wiklund P.; Menon M.; Tewari A. 07-01-2022. The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Signific European Urology Open Science, 41 , 45-54

Falagario U.G.; Ratnani P.; Lantz A.; Jambor I.; Dovey Z.; Verma A.; Treacy P.J.; Sobotka S.; Martini A.; Bashorun H.; Ashan M.; Wagaskar V.G.; Lewis S.; Cormio L.; Carrieri G.; Kyprianou N.; Mohamed N.; Tewari A. 07-01-2020. Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men Journal of Urology, 204 1, 82-89

Bravi C.A.; Tin A.; Vertosick E.; Mazzone E.; Martini A.; Dell'oglio P.; Stabile A.; Gandaglia G.; Fossati N.; Suardi N.; Gallina A.; Briganti A.; Montorsi F.; Vickers A. 07-01-2019. The Impact of Experience on the Risk of Surgical Margins and Biochemical Recurrence after Robot-Assi Journal of Urology, 202 1, 108-113

Falagario U.G.; Beksac A.T.; Martini A.; Cumarasamy S.; Gupta A.; Prasad S.; Thulasidass H.; Shah Q.N.; Jayaratna I.; Lewis S.; Rastinehad A.R.; Taouli B.; Cormio L.; Carrieri G.; Tewari A.K. 07-01-2019. Defining Prostate Cancer at Favorable Intermediate Risk: The Potential Utility of Magnetic Resonance Journal of Urology, 202 1, 102-106

Martini A.; Cumarasamy S.; Haines K.G.; Tewari A.K. 07-01-2019. An updated approach to incremental nerve sparing for robot-assisted radical prostatectomy BJU International, 124 1, 103-108

Martini A.; Gandaglia G.; Karnes R.J.; Zaffuto E.; Bianchi M.; Gontero P.; Chlosta P.; Gratzke C.; Graefen M.; Tilki D.; Cucchiara V.; Mirone V.; Kneitz B.; Sanchez Salas R.; Van Der Poel H.; Tombal B.; Spahn M.; Joniau T.S.; Montorsi F.; Briganti A. 07-01-2019. Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Pat European Urology Oncology, 2 4, 456-463

Martini A.; Sfakianos J.P.; Paulucci D.J.; Abaza R.; Eun D.D.; Bhandari A.; Hemal A.K.; Badani K.K. 07-01-2019. Predicting acute kidney injury after robot-assisted partial nephrectomy: Implications for patient se Urologic Oncology: Seminars and Original Investigations, 37 7, 445-451

Martini A.; Wang J.; Brown N.M.; Cumarasamy S.; Sfakianos J.P.; Rastinehad A.R.; Haines K.G.; Wiklund N.P.; Nair S.S.; Tewari A.K. 07-01-2019. A transcriptomic signature of tertiary Gleason 5 predicts worse clinicopathological outcome BJU International, 124 1, 155-162

Alfred Witjes J.; Bruins H.M.; Carrión A.; Cathomas R.; Compérat E.; Efstathiou J.A.; Fietkau R.; Gakis G.; Lorch A.; Martini A.; Mertens L.S.; Meijer R.P.; Milowsky M.I.; Neuzillet Y.; Panebiaco V.; Redlef J.; Rink M.; Rouanne M.; Thalmann G.N.; Sæbjørnsen S.; Veskimäe E.; Mariappan P.; van der Heijden A.G. 06-01-2024. Corrigendum to “European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder European Urology, 85 6, e180

Bonavina G.; Busnelli A.; Acerboni S.; Martini A.; Candiani M.; Bulfoni A. 06-01-2024. Surgical repair of post-cesarean vesicouterine fistula: A systematic review and a plea for preventio International Journal of Gynecology and Obstetrics, 165 3, 894-915

Contieri R.; Tan W.S.; Grajales V.; Hensley P.J.; Martini A.; Bree K.; Myers A.; Nogueras-Gonzalez G.; Navai N.; Dinney C.P.; Guo C.; Kamat A.M. 06-01-2024. Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer i BJU International, 133 6, 733-741

Pellegrino F.; Martini A.; Falagario U.G.; Rautiola J.; Russo A.; Mertens L.S.; Di Gianfrancesco L.; Bravi C.A.; Vollemaere J.; Abdeen M.; Moschini M.; Mendrek M.; Kjøbli E.; Buse S.; Wijburg C.; Touzani A.; Ploussard G.; Antonelli A.; Schwenk L.; Ebbing J.; Vasdev N.; Froelicher G.; John H.; Canda A.E.; Balbay M.D.; Stoll M.; Edeling S.; Berquin C.; Van Praet C.; Leyh-Bannurah S.R.; Siemer S.; Stoeckle M.; Mottrie A.; D'Hondt F.; Crestani A.; Porreca A.; Briganti A.; Montorsi F.; van der Poel H.; Dacaestecker K.; Gaston R.; Hosseini A.; Wiklund N.P. 06-01-2024. How can we reduce morbidity after robot-assisted radical cystectomy with intracorporeal neobladder? BJU International, 133 6, 673-677

Bravi C.A.; Piazza P.; Mazzone E.; Dell’Oglio P.; Rosiello G.; Martini A.; Stabile A.; Moschini M.; Amato M.; Sarchi L.; Peraire M.; Farinha R.; Scarcella S.; Puliatti S.; Knipper S.; Berquin C.; Develtere D.; Sinatti C.; Van Puyvelde H.; De Groote R.; De Naeyer G.; D’Hondt F.; Schatteman P.; Briganti A.; Montorsi F.; Mottrie A. 06-01-2023. Long-term oncologic outcomes of robot-assisted radical cystectomy: update series from a high-volume Journal of Robotic Surgery, 17 3, 1143-1150

Fallara G.; Robesti D.; Raggi D.; Montorsi F.; Necchi A.; Cooperberg M.R.; Malavaud B.; Ploussard G.; Martini A. 06-01-2023. Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castratio European Urology Open Science, 52 , 40-43

Sacco M.; Gandaglia G.; Aas K.; Ceci F.; Chiu P.; Fankhauser C.D.; Fournier G.; Heiddeger I.; Kasivisvanathan V.; Kesch C.; Maggi M.; Martini A.; Olivier J.; Ploussard G.; Preisser F.; Puche-Sanz I.; Rajwa P.; Soeterik T.; Thibault C.; Valerio M.; van den Bergh R.C.N.; Zattoni F.; Rivas J.G.; Moschini M.; Gillessen S.; Bossi A.; Gontero P.; Marra G. 06-01-2023. The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Er Clinical Genitourinary Cancer, 21 3, 416.e1-416.e10

Martini A.; Lonati C.; Montorsi F.; Briganti A.; Colombo R.; Necchi A.; Simeone C.; Zamboni S.; Afferi L.; Mattei A.; Carando R.; Ploussard G.; Soria F.; Marra G.; Rouprêt M.; Xylinas E.; Pradere B.; Abufaraj M.; D'Andrea D.; Shariat S.F.; Moschini M. 06-01-2022. The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy Clinical Genitourinary Cancer, 20 3, e190-e198

Martini A.; Raggi D.; Marandino L.; Montorsi F.; Ross J.S.; Gibb E.A.; Necchi A. 06-01-2022. The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Ne European urology oncology, 5 3, 370-372

Rosiello G.; Larcher A.; Fallara G.; Giancristofaro C.; Martini A.; Re C.; Cei F.; Musso G.; Tian Z.; Karakiewicz P.I.; Mottrie A.; Bertini R.; Salonia A.; Necchi A.; Raggi D.; Briganti A.; Montorsi F.; Capitanio U. 06-01-2022. Head-to-head comparison of all the prognostic models recommended by the European Association of Urol Urologic Oncology: Seminars and Original Investigations, 40 6, 271.e19-271.e27

Martini A.; Falagario U.G.; Cumarasamy S.; Abaza R.; Eun D.D.; Bhandari A.; Porter J.R.; Hemal A.K.; Badani K.K. 06-01-2021. Defining Risk Categories for a Significant Decline in Estimated Glomerular Filtration Rate After Rob European Urology Oncology, 4 3, 498-501

Martini A.; Larcher A.; Bravi C.A.; Capogrosso P.; Falagario U.G.; Fallara G.; Pellegrino F.; Muttin F.; Re C.; Briganti A.; Salonia A.; Bertini R.; Montorsi F.; Capitanio U. 06-01-2021. How to Select the Optimal Candidates for Renal Mass Biopsy European urology oncology, 4 3, 506-509

Moschini M.; Martini A.; Zamboni S.; Mattei A.; Baumeister P.; Di Bona C.; Dell'Oglio P.; Zaffuto E.; Burgio G.; Shariat S.F.; Sanchez-Salas R.; Cathelineau X.; Salonia A.; Montorsi F.; Briganti A.; Gallina A.; Colombo R. 06-01-2019. Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact o Clinical Genitourinary Cancer, 17 3, e541-e548

Badani K.K.; Reddy B.N.; Moskowitz E.J.; Paulucci D.J.; Beksac A.T.; Martini A.; Whalen M.J.; Skarecky D.W.; Huynh L.M.; Ahlering T.E. 06-01-2018. Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in pati Urologic Oncology: Seminars and Original Investigations, 36 6, 310.e1-310.e6

Grajales V.; Martini A.; Shore N.D. 05-01-2024. Complications of immuno-oncology care: what urologist should know BJU International, 133 5, 524-531

Lonati C.; Afferi L.; Mari A.; Minervini A.; Krajewski W.; Borghesi M.; Schulz G.B.; Rink M.; Montorsi F.; Briganti A.; Colombo R.; Martini A.; Necchi A.; Contieri R.; Hurle R.; Umari P.; Zamboni S.; Simeone C.; Soria F.; Marra G.; Gontero P.; Teoh J.Y.C.; Klatte T.; Bajeot A.S.; Roumiguié M.; Rouprêt M.; Masson-Lecomte A.; Laukhtina E.; Valiquette A.S.; Mir M.C.; Antonelli A.; Einerhand S.M.H.; Hendricksen K.; Carando R.; Fankhauser C.D.; Baumeister P.; Mattei A.; Shariat S.F.; Moschini M. 05-01-2022. Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous World Journal of Urology, 40 5, 1167-1174

Martini A.; Fallara G.; Pellegrino F.; Cirulli G.O.; Larcher A.; Necchi A.; Montorsi F.; Capitanio U. 05-01-2021. Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma World Journal of Urology, 39 5, 1369-1376

Veccia A.; Falagario U.; Martini A.; Marchioni M.; Antonelli A.; Simeone C.; Cormio L.; Capitanio U.; Mir M.C.; Derweesh I.; Van Poppel H.; Porpiglia F.; Autorino R. 05-01-2021. Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Syst European Urology Focus, 7 3, 574-581

Beksac A.T.; Sobotka S.; Xu P.; Gupta A.; Treacy P.J.; Weil R.; Mahajan K.; Prasad S.; Cumarasamy S.; Martini A.; Falagario U.; Rastinehad A.; Tewari A.K. 05-01-2019. Downgrading of Grade Group After Radical Prostatectomy: Comparison of Multiparametric Magnetic Reson Urology, 127 , 80-85

Martini A.; Cumarasamy S.; Moschini M.; Tewari A. 05-01-2018. The role of antibiotic prophylaxis after radical cystectomy in preventing urinary tract infections a Translational Andrology and Urology, 7 4, 752-753

Martini A.; Nicita G. 05-01-2018. Re: Serra-Aracil et al.: The Place of Transanal Endoscopic Surgery in the Treatment of Rectourethral Urology, 115 , 193-194

Moschini M.; Zamboni S.; Mattei A.; Martini A.; Zaffuto E.; Briganti A.; Gallina A.; Montorsi F. 05-01-2018. Evaluating the role of neoadjuvant chemotherapy in bladder cancer patients with occult lymph node me Translational Andrology and Urology, 7 4, 742-744

Bravi C.A.; Mazzone E.; Dell'Oglio P.; Covas Moschovas M.; Martini A.; Rosiello G.; Piazza P.; Mottaran A.; Paciotti M.; Sarchi L.; Puliatti S.; Knipper S.; de Groote R.; Schiavina R.; Rocco B.; Galfano A.; Briganti A.; Montorsi F.; Patel V.; Mottrie A. 04-01-2023. A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with Minerva Urology and Nephrology, 75 2, 231-234

Treacy P.J.; Martini A.; Falagario U.G.; Ratnani P.; Wajswol E.; Beksac A.T.; Wiklund P.; Nair S.; Kyprianou N.; Durand M.; Tewari A.K. 04-01-2023. Association between Expression of Connective Tissue Genes and Prostate Cancer Growth and Progression International Journal of Molecular Sciences, 24 8,

Lantz A.; Falagario U.G.; Ratnani P.; Jambor I.; Dovey Z.; Martini A.; Lewis S.; Lundon D.; Nair S.; Phillip D.; Haines K.; Cormio L.; Carrieri G.; Kryprianou N.; Tewari A. 04-01-2022. Expanding Active Surveillance Inclusion Criteria: A Novel Nomogram Including Preoperative Clinical P European urology oncology, 5 2, 187-194

Martini A.; Touzani A.; Mazzone E.; Roumiguié M.; Marra G.; Valerio M.; Beauval J.B.; Campi R.; Minervini A.; van den Berg R.C.N.; van den Berg R.C.N.; Soeterik T.F.W.; Zhuang J.; Guo H.; Gontero P.; Montorsi F.; Briganti A.; Gandaglia G.; Ploussard G. 04-01-2022. Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions Prostate Cancer and Prostatic Diseases, 25 4, 794-796

Martini A.; Fossati N.; Karnes R.J.; Boorjian S.A.; Boeri L.; Bossi A.; Di Muzio N.; Cozzarini C.; Noris Chiorda B.; Gandaglia G.; Robesti D.; Bartkowiak D.; Böhmer D.; Shariat S.F.; Goldner G.; Battaglia A.; Joniau S.; Berghen C.; De Meerleer G.; Fonteyne V.; Ost P.; Van Poppel H.; Montorsi F.; Wiegel T.; Briganti A. 04-01-2021. Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radi European urology oncology, 4 2, 301-304

Montorsi F.; Martini A. 04-01-2021. Re: Mathieu Rouanne, Dean F. Bajorin, Raquibul Hannan, et al. Rationale and Outcomes for Neoadjuvant European urology oncology, 4 2, 336

Pfail J.L.; Katims A.B.; Gul Z.; Rosenzweig S.J.; Razdan S.; Nathaniel S.; Martini A.; Mehrazin R.; Wiklund P.N.; Loftus K.; Sim A.; DeMaria S.; Sfakianos J.P. 04-01-2021. Can anesthetics affect bladder cancer recurrence? Total intravenous versus volatile anesthesia in pa Urologic Oncology: Seminars and Original Investigations, 39 4, 233.e1-233.e8

Cumarasamy S.; Martini A.; Falagario U.G.; Gul Z.; Beksac A.T.; Jayaratna I.; Haines G.K.; Carrieri G.; Tewari A. 04-01-2020. Development of a model to predict prostate cancer at the apex (PCAP model) in patients undergoing ro World Journal of Urology, 38 4, 813-819

Falagario U.G.; Martini A.; Pfail J.; Treacy P.J.; Okhawere K.E.; Dayal B.D.; Sfakianos J.P.; Abaza R.; Eun D.D.; Bhandari A.; Porter J.R.; Hemal A.K.; Badani K.K. 04-01-2020. Does race impact functional outcomes in patients undergoing robotic partial nephrectomy? Translational Andrology and Urology, 9 2, 863-869

Jambor I.; Falagario U.; Ratnani P.; Perez I.M.; Demir K.; Merisaari H.; Sobotka S.; Haines G.K.; Martini A.; Beksac A.T.; Lewis S.; Pahikkala T.; Wiklund P.; Nair S.; Tewari A. 04-01-2020. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using r Journal of Magnetic Resonance Imaging, 51 4, 1075-1085

Wajswol E.; Winoker J.S.; Anastos H.; Falagario U.; Okhawere K.; Martini A.; Treacy P.J.; Voutsinas N.; Knauer C.J.; Sfakianos J.P.; Lewis S.C.; Taouli B.A.; Rastinehad A.R. 04-01-2020. A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fus BJU International, 125 4, 531-540

Martini A.; Gupta A.; Cumarasamy S.; Lewis S.C.; Haines K.G.; Briganti A.; Montorsi F.; Tewari A.K. 04-01-2019. Novel nomogram for the prediction of seminal vesicle invasion including multiparametric magnetic res International Journal of Urology, 26 4, 458-464

Martini A.; Gupta A.; Cumarasamy S.; Tewari A.K. 04-01-2018. Re: Rita Faria, Marta O. Soares, Eldon Spackman, et al. Optimising the Diagnosis of Prostate Cancer European Urology, 73 4, e108-e109

Martini A.; Marqueen K.E.; Falagario U.G.; Waingankar N.; Wajswol E.; Khan F.; Fossati N.; Briganti A.; Montorsi F.; Tewari A.K.; Stock R.; Rastinehad A.R. 03-31-2020. Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prost JAMA Network Open, 3 3, E201913

Pellegrino F.; Tin A.L.; Martini A.; Vertosick E.A.; Porwal S.P.; Stabile A.; Gandaglia G.; Eastham J.A.; Briganti A.; Montorsi F.; Vickers A.J. 03-01-2023. Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients w European Urology Focus, 9 2, 291-297

Rosiello G.; Larcher A.; Fallara G.; Cignoli D.; Re C.; Martini A.; Tian Z.; Karakiewicz P.I.; Mottrie A.; Boarin M.; Villa G.; Trevisani F.; Marandino L.; Raggi D.; Necchi A.; Bertini R.; Salonia A.; Briganti A.; Montorsi F.; Capitanio U. 03-01-2023. A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patie Urologic Oncology: Seminars and Original Investigations, 41 3, 149.e17-149.e25

Dovey Z.; Pfail J.; Martini A.; Steineck G.; Dey L.; Renström L.; Hosseini A.; Sfakianos J.P.; Wiklund P. 03-01-2022. Bladder Cancer (NMIBC) in a population-based cohort from Stockholm County with long-term follow-up; Urologic Oncology: Seminars and Original Investigations, 40 3, 106.e1-106.e10

Martini A.; Falagario U.G.; Cumarasamy S.; Jambor I.; Wagaskar V.G.; Ratnani P.; Haines K.G.; Tewari A.K. 03-01-2022. The Role of 3D Models Obtained from Multiparametric Prostate MRI in Performing Robotic Prostatectomy Journal of Endourology, 36 3, 387-393

Martini A.; Raggi D.; Fallara G.; Nocera L.; Schultz J.G.; Belladelli F.; Marandino L.; Salonia A.; Briganti A.; Montorsi F.; Powles T.; Necchi A. 03-01-2022. Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systemat Cancer Treatment Reviews, 104 ,

Montorsi F.; Martini A.; Gandaglia G.; Fossati N.; Stabile A.; Dehò F.; Salonia A.; Briganti A. 03-01-2022. Metastatic hormone-sensitive prostate cancer: local treatment strategies World Journal of Urology, 40 3, 881-882

Rosiello G.; Gandaglia G.; Scuderi S.; Barletta F.; Fossati N.; Stabile A.; Gallina A.; Mazzone E.; Vitale L.M.; Pellegrino A.; Bravi C.; Martini A.; Cucchiara V.; Karakiewicz P.I.; Mottrie A.; Briganti A.; Montorsi F. 03-01-2022. Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prost European Urology Focus, 8 2, 431-437

Waingankar N.; Martini A.; Griffiths L.; Shah P.; Paulucci D.J.; Kotamarti S.; Gul Z.; Elmasri M.; Yaskiv O.; Haines K.; Lerner S.; Vira M.; Kavoussi L.R.; Tewari A.K.; Kapoor D.A.; Olsson C.A. 03-01-2020. Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic p Urologic Oncology: Seminars and Original Investigations, 38 3, 78.e15-78.e21

Nicita G.; Villari D.; Li Marzi V.; Milanesi M.; Saleh O.; Jaeger T.; Martini A. 03-01-2018. Long-term experience with a novel uterine-sparing transvaginal mesh procedure for uterovaginal prola European Journal of Obstetrics and Gynecology and Reproductive Biology, 222 , 57-63

Caroassai Grisanti S.; Martini A.; Bigazzi B.; Raspollini M.; Delle Rose A.; Villari D.; Nicita G. 03-01-2016. Conservative Treatment of Serous Borderline Paratesticular Tumor in a Pediatric Patient Urology, 89 , 123-125

Basile G.; Gallioli A.; Martini A.; Verri P.; Robalino J.; Dieguez L.; Gavrilov P.; Territo A.; Uleri A.; Gaya J.M.; Algaba F.; Palou J.; Breda A. 02-01-2024. Oncologic surveillance intensity after endoscopic treatment of upper tract urothelial carcinoma Minerva Urology and Nephrology, 76 1, 88-96

Falagario U.G.; Martini A.; Pellegrino F.; Carrieri G.; Manon M.; Lantz A.; Wiklund P. 02-01-2024. Re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. Prostate-specific Antigen Level at the Time of Salva European urology oncology, 7 1, 167-168

Robesti D.; Nocera L.; Belladelli F.; Schultz J.G.; Fallara G.; Marandino L.; Raggi D.; Montorsi F.; Msaouel P.; Necchi A.; Martini A. 02-01-2024. The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after BJU International, 133 2, 158-168

Baboudjian M.; Touzani A.; Martini A.; Diamand R.; Roche J.B.; Lacetera V.; Beauval J.B.; Gondran-Tellier B.; Roumeguère T.; Simone G.; Windisch O.; Benamran D.; Fourcade A.; Fiard G.; van Den Bergh R.C.; Peltier A.; Ploussard G. 02-01-2023. Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE crite Minerva Urology and Nephrology, 75 1, 124-126

Martini A.; Valerio M. 02-01-2023. An Algorithm to Personalize Nerve Sparing in Men With Unilateral High-risk Prostate Cancer. Reply. Journal of Urology, 209 2, 325

Lonati C.; Necchi A.; Gómez Rivas J.; Afferi L.; Laukhtina E.; Martini A.; Ventimiglia E.; Colombo R.; Gandaglia G.; Salonia A.; Briganti A.; Montorsi F.; Mattei A.; Simeone C.; Carlo M.I.; Shariat S.F.; Spiess P.E.; Moschini M. 02-01-2022. Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview fro European urology oncology, 5 1, 30-41

Martini A.; Soeterik T.F.W.; Haverdings H.; Rahota R.G.; Checcucci E.; De Cillis S.; Hermanns T.; Fankhauser C.D.; Afferi L.; Moschini M.; Mattei A.; Kesch C.; Heidegger I.; Preisser F.; Zattoni F.; Marquis A.; Marra G.; Gontero P.; Briganti A.; Montorsi F.; Porpiglia F.; Van Basten J.P.; Van Den Bergh R.C.N.; Van Melick H.H.E.; Ploussard G.; Gandaglia G.; Valerio M. 02-01-2022. An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer Journal of Urology, 207 2, 350-357

Montoya Perez I.; Merisaari H.; Jambor I.; Ettala O.; Taimen P.; Knaapila J.; Kekki H.; Khan F.L.; Syrjälä E.; Steiner A.; Syvänen K.T.; Verho J.; Seppänen M.; Rannikko A.; Riikonen J.; Mirtti T.; Lamminen T.; Saunavaara J.; Falagario U.; Martini A.; Pahikkala T.; Pettersson K.; Boström P.J.; Aronen H.J. 02-01-2022. Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospe Journal of Magnetic Resonance Imaging, 55 2, 465-477

Tafuri A.; Sandri M.; Martini A.; Capitanio U.; Mantica G.; Terrone C.; Furlan M.; Simeone C.; Amparore D.; Porpiglia F.; Minervini A.; Mari A.; Cerruto M.A.; Antonelli A. 02-01-2022. External validation of the Palacios’ equation: a simple and accurate tool to estimate the new baseli World Journal of Urology, 40 2, 467-473

Martini A.; Gandaglia G.; Fossati N.; Scuderi S.; Bravi C.A.; Mazzone E.; Stabile A.; Scarcella S.; Robesti D.; Barletta F.; Cucchiara V.; Mirone V.; Montorsi F.; Briganti A. 02-01-2021. Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectom European urology oncology, 4 1, 42-48

Martini A.; Sfakianos J.P.; Renström-Koskela L.; Mortezavi A.; Falagario U.G.; Egevad L.; Hosseini A.; Mehrazin R.; Galsky M.D.; Steineck G.; Wiklund N.P. 02-01-2020. The natural history of untreated muscle-invasive bladder cancer BJU International, 125 2, 270-275

Alfred Witjes J.; Max Bruins H.; Carrión A.; Cathomas R.; Compérat E.; Efstathiou J.A.; Fietkau R.; Gakis G.; Lorch A.; Martini A.; Mertens L.S.; Meijer R.P.; Milowsky M.I.; Neuzillet Y.; Panebianco V.; Redlef J.; Rink M.; Rouanne M.; Thalmann G.N.; Sæbjørnsen S.; Veskimäe E.; van der Heijden A.G. 01-01-2024. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary European Urology, 85 1, 17-31

Contieri R.; Grajales V.; Tan W.S.; Martini A.; Sood A.; Hensley P.; Bree K.; Lobo N.; Nogueras-Gonzalez G.M.; Guo C.C.; Navai N.; Dinney C.P.; Kamat A.M. 01-01-2024. Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder BJU International, 133 1, 63-70

Contieri R.; Martini A.; Mertens L.S.; Giannatempo P.; Hurle R.; Witjes J.A.; Ribal M.J.; van Rhijn B.W.G.; Malavaud B. 01-01-2024. The Financial Burden of Guideline-recommended Cancer Medications for Metastatic Urothelial Carcinoma European Urology Focus, ,

Martini A.; Wever L.; Soeterik T.F.W.; Rakauskas A.; Fankhauser C.D.; Grogg J.B.; Checcucci E.; Amparore D.; Haiquel L.; Rodriguez-sanchez L.; Ploussard G.; Qiang P.; Affentranger A.; Marquis A.; Marra G.; Ettala O.; Zattoni F.; Falagario U.G.; De Angelis M.; Kesch C.; Apfelbeck M.; Al-Hammouri T.; Kretschmer A.; Kasivisvanathan V.; Preisser F.; Lefebvre E.; Olivier J.; Radtke J.P.; Carrieri G.; Moro F.D.; Boström P.; Jambor I.; Gontero P.; Chiu P.K.; John H.; Macek P.; Porpiglia F.; Hermanns T.; van den Bergh R.C.N.; van Basten J.P.A.; Gandaglia G.; Valerio M. 01-01-2024. An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted bi Prostate Cancer and Prostatic Diseases, ,

Rodriguez-Sanchez L.; Martini A.; Martini A.; Zhuang J.; Guo H.; Rajwa P.; Rajwa P.; Mandoorah Q.; Haiquel L.; Shariat S.F.; Gandaglia G.; Valerio M.; Marra G. 01-01-2024. External validation of an algorithm to personalize nerve sparing approaches during robot-assisted ra Prostate Cancer and Prostatic Diseases, ,

Touzani A.; D'Agate D.; Kesch C.; Calleris G.; Buhas B.; Abou-Zahr R.; Rahota R.G.; Ouzzane A.; Pradère B.; Tollon C.; Martini A.; Ploussard G. 01-01-2024. One-year outcomes of same-day-discharge robot-assisted radical prostatectomy BJU International, ,

Windisch O.; Diana M.; Tilki D.; Marra G.; Martini A.; Valerio M. 01-01-2024. Intraoperative technologies to assess margin status during radical prostatectomy – a narrative revie Prostate Cancer and Prostatic Diseases, ,

Bravi C.A.; Gandaglia G.; Mazzone E.; Fossati N.; Gallina A.; Stabile A.; Scuderi S.; Barletta F.; Nocera L.; Rosiello G.; Martini A.; Pellegrino F.; Cucchiara V.; Dehò F.; Capitanio U.; Scattoni V.; Salonia A.; Briganti A.; Montorsi F. 01-01-2023. Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted R European Urology Focus, 9 1, 83-88

Falagario U.G.; Chakravarty D.; Martini A.; Shahait M.; El-Fahmawi A.; Jambor I.; Lantz A.; Grannas D.; Ratnani P.; Parekh S.; Lundon D.; Haines K.; Cormio L.; Carrieri G.; Kyprianou N.; Kattan M.W.; Klein E.A.; Wiklund P.; Lee D.I.; Tewari A. 01-01-2023. When to order genomic tests: development and external validation of a model to predict high-risk pro World Journal of Urology, 41 1, 85-92

Martini A.; Tholomier C.; Mokkapati S.; Dinney C.P.N. 01-01-2023. Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval Frontiers in Immunology, 14 ,

Saouli A.; Touzani A.; Martini A.; Beauval J.B.; Dergamoun H.; Ziouziou I.; Deffar N.; Ploussard G.; Ouzzane A. 01-01-2023. Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A sy Prostate Cancer and Prostatic Diseases, ,

Tholomier C.; Martini A.; Mokkapati S.; Dinney C.P. 01-01-2023. The current status of gene therapy in bladder cancer Expert Review of Anticancer Therapy, 23 5, 531-543

Cirulli G.O.; Larcher A.; Montorsi F.; Martini A. 01-01-2022. Metabolic Syndrome, Obesity and Cancer Risk Men’s Health and Wellbeing, , 95-119

Kretschmer A.; Van Den Bergh R.C.N.; Martini A.; Marra G.; Valerio M.; Tsaur I.; Heidegger I.; Kasivisvanathan V.; Kesch C.; Preisser F.; Fankhauser C.D.; Zattoni F.; Ceci F.; Olivier J.; Chiu P.; Puche-Sanz I.; Thibault C.; Gandaglia G.; Tilki D. 01-01-2022. Assessment of health-related quality of life in patients with advanced prostate cancer—current state Cancers, 14 1,

Lobo N.; Martini A.; Kamat A.M. 01-01-2022. Evolution of immunotherapy in the treatment of non-muscle-invasive bladder cancer Expert Review of Anticancer Therapy, 22 4, 361-370

Martini A.; Larcher A. 01-01-2022. The Future of Artificial Intelligence Applied to Perioperative Immunotherapy Trials: Renal Cell Carc Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers: Multidisciplinary Management, , 299-302

Martini A.; Montorsi F. 01-01-2022. The Future of Artificial Intelligence Applied to Perioperative Immunotherapy Trials: Prostate Cancer Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers: Multidisciplinary Management, , 295-297

Necchi A.; Martini A.; Raggi D.; Cucchiara V.; Colecchia M.; Lucianò R.; Villa L.; Mazzone E.; Basile G.; Scuderi S.; Pederzoli F.; Bandini M.; Barletta F.; Larcher A.; Capitanio U.; Salonia A.; Briganti A.; Ross J.S.; Messina A.; Montorsi F. 01-01-2022. A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with Urologic Oncology: Seminars and Original Investigations, 40 1, 10.e1-10.e6

Rocco B.; Martini A.; Sighinolfi M.C.; Ko Y.H. 01-01-2022. Techniques to Improve Urinary Continence Outcomes Following Robot-Assisted Radical Prostatectomy Robotic Urologic Surgery: Third Edition, , 217-223

Wagaskar V.G.; Barthe F.; Martini A.; Sooriakumaran P.; Tewari A. 01-01-2022. Oligometastatic prostate cancer: a new horizon for robotic radical prostatectomy Mini-invasive Surgery, 6 ,

Falagario U.G.; Lantz A.; Jambor I.; Martini A.; Ratnani P.; Wagaskar V.; Treacy P.J.; Veccia A.; Bravi C.A.; Bashorun H.O.; Phillip D.; Lewis S.; Haines K.; Cormio L.; Carrieri G.; Tewari A. 01-01-2021. Using biomarkers in patients with positive multiparametric magnetic resonance imaging: 4Kscore predi International Journal of Urology, 28 1, 47-52

Martini A. 01-01-2021. On the use of the “Population Attributable Fraction”: application in cost estimation Translational Andrology and Urology, 10 1, 22-23

Martini A.; Falagario U.G.; Bravi C.A.; Abaza R.; Eun D.D.; Bhandari A.; Porter J.R.; Capitanio U.; Montorsi F.; Hemal A.K.; Badani K.K. 01-01-2021. Editorial Comment from Dr Martini et al. to Independent external validation of a nomogram to define International Journal of Urology, 28 1, 80-81

Martini A.; Gandaglia G.; Nicita G.; Montorsi F. 01-01-2021. RE: Validating the Martini Staging System for Rectourethral Fistula: A Meta-analysis of Postoperativ Urology, 147 , 323

Pfail J.L.; Audenet F.; Martini A.; Tomer N.; Paranjpe I.; Daza J.; Attalla K.; Waingankar N.; Mehrazin R.; Wiklund P.; Galsky M.D.; Sfakianos J.P. 01-01-2020. Survival of patients with muscle-invasive urothelial cancer of the bladder with residual disease at Bladder Cancer, 6 3, 265-276

Tam A.W.; Liaw C.; Li E.; Katims A.B.; Say R.K.; Gul Z.; Winoker J.S.; Martini A.; Audenet F.; Sfakianos J.P. 01-01-2020. The effect of tumor location on overall survival for pT2-4 bladder and upper tract urothelial carcin Canadian Urological Association Journal, 15 5,

Arroyo C.; Martini A.; Wang J.; Tewari A.K. 01-01-2019. Anatomical, surgical and technical factors influencing continence after radical prostatectomy Therapeutic Advances in Urology, 11 ,

Beksac A.; Reddy B.; Martini A.; Paulucci D.; Moshier E.; Abaza R.; Eun D.; Hemal A.; Badani K. 01-01-2019. Hypertension and diabetes mellitus are not associated with worse renal functional outcome after part International Journal of Urology, 26 1, 120-125

Beksac A.T.; Paulucci D.J.; Gul Z.; Reddy B.N.; Kannappan M.; Martini A.; Sfafakianos J.P.; Gin G.E.; Abaza R.; Eun D.D.; Bhandari A.; Hemal A.K.; Porter J.; Badani K.K. 01-01-2019. Risk factors and prognostic implications for pathologic upstaging to T3a after partial nephrectomy Minerva Urologica e Nefrologica, 71 4, 395-405

Dr A.M.; Cumarasamy S.; Hemal A.K.; Badani K.K. 01-01-2019. Renal cell carcinoma: The oncological outcome is not the only endpoint Translational Andrology and Urology, 8 , S93-S95

Martini A.; Gandaglia G.; Briganti A. 01-01-2019. What is new in robot-assisted radical prostatectomy: A narrative review Current Opinion in Urology, 29 1, 14-18

Martini A.; Tewari A.K. 01-01-2019. Anatomic robotic prostatectomy: current best practice Therapeutic Advances in Urology, 11 ,

Martini A.; Wagaskar V.G.; Dell'oglio P.; Rastinehad A.R.; Sfakianos J.P.; Tewari A.K. 01-01-2019. Image guidance in robot-assisted radical prostatectomy: How far do we stand? Current Opinion in Urology, 29 1, 10-13

Villa L.; Capogrosso P.; Capitanio U.; Martini A.; Briganti A.; Salonia A.; Montorsi F. 01-01-2019. Silodosin: An Update on Efficacy, Safety and Clinical Indications in Urology Advances in Therapy, 36 1,

Martini A.; Villari D.; Nicita G. 01-01-2017. Editorial comment to: Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy International Journal of Surgery, 37 , 13-14

Nicita G.; Villari D.; Caroassai Grisanti S.; Marzocco M.; Li Marzi V.; Martini A. 01-01-2017. Minimally Invasive Transanal Repair of Rectourethral Fistulas European Urology, 71 1, 133-138